Human reproductive failure may be a consequence of aberrant expression of immunological factors during pregnancy. Although the relative importance of immunological factors in human reproduction remains controversial, substantial evidence suggests that human leukocyte antigens (HLA), antisperm antibodies, integrins, the leukaemia inhibitory factor (LIF), cytokines, antiphospholipid antibodies, endometrial adhesion factors, mucins (MUC1) and uterine natural killer cells contribute to reproductive failure. In contrast, fewer data support the roles of anti-trophoblast antibodies, anti-endometrial antibodies, T-cells, peripheral natural killer cells, anti-HLA antibodies, blocking antibodies and suppressor cells in reproductive failure. Although immunological factors involved in reproductive failure have been studied traditionally using assays for antibodies and/or antigens, detailed research on these factors demonstrates con¯icting results in humans. Maternal and fetal immunology is also dif®cult to investigate in humans. For these reasons, molecular assays may serve as a valuable alternative to investigate how the immune system affects reproductive outcome. In Part I of this review, immunological factors involved in human reproductive failure are summarized and critically evaluated. Immunogenetic and interacting factors in human reproductive failure will be summarized and evaluated in Part II.
Introduction
Human reproductive failure, or the inability to conceive or to carry a pregnancy to term, is a surprisingly frequent event. It is estimated that fetal viability is only achieved in 30% of all human conceptions, 50% of which are lost prior to the ®rst missed menses (Edmonds et al., 1982) . In humans,~25% of implanted embryos are resorbed within 7-14 days after attachment to the uterine endometrium (Baines and Gendron, 1993) . The loss of clinically recognized pregnancies prior to the 20th week of gestation occurs at a frequency of 15% (Warburton and Fraser, 1963; Alberman, 1988 ); yet, these percentages may underestimate the actual frequency of reproductive failure.
There are many categories of human reproductive failure, including infertility, unexplained infertility, pregnancy wastage, miscarriage, recurrent miscarriage, habitual abortion, recurrent abortion, spontaneous abortion, spontaneous miscarriage and recurrent spontaneous abortion. Unfortunately, the nomenclature is complicated by synonymous usage of terms by some authors, but not by others. Without standardized terminology, these classi®cations are vague and fraught with dif®culties in de®ning the type and time period of reproductive loss, thereby complicating comparisons between studies. For this review, most de®ni-tions are drawn from Reiss (1998) .
Categories of reproductive failure are de®ned as follows. Infertility is the failure to conceive after frequent unprotected intercourse (Reiss, 1998) . Unexplained infertility occurs when no cause of infertility can be identi®ed after full clinical investigation of both partners (Reiss, 1998) . Legally, in the UK, miscarriage is de®ned as the spontaneous loss of a pregnancy with a gestational age of 24 weeks or less (Regan, 1997; Reiss, 1998) . Alternatively, the World Health Organization (WHO) has de®ned a miscarriage as the loss of a fetus or embryo weighing`500 g, which would normally be at 20±22 complete weeks of gestation (WHO, 1977) . Recurrent miscarriage, used synonymously with habitual miscarriage, habitual abortion or recurrent abortion, is de®ned as the loss of three or more consecutive pregnancies before the 24th week of gestation (Reiss, 1998) . Some authors also use the terms recurrent miscarriage and recurrent spontaneous abortion (RSA) interchangeably. However, RSA has been de®ned as the loss of two or more, or even three or more, clinically detectable pregnancies with no reference to the week of gestation. Due to the discrepancy between the number of losses and time period of reproductive failure, this review differentiates between studies involving women with RM and RSA. Finally, reproductive success is de®ned as the ability to conceive and carry a pregnancy to term and reproductive outcome refers to both reproductive failure and success.
Immunological factors
A substantial proportion of miscarriages is caused by chromosomal, anatomical and endocrinological abnormalities or infections (for review, see Christiansen, 1996) . Although there is little agreement regarding the proportion of fetal loss due to these causes, up to 40% of fetal losses remain a consequence of unexplained aetiology (Boue et al., 1985) . In 1953, Medawar suggested that the fetus represents an immunologically foreign graft that is maternally tolerated during pregnancy. Fetalplacental tissues were believed to be immunologically foreign to the maternal host, due to the presence of paternally inherited gene products and tissue-speci®c differentiation antigens. Thus, pregnancy loss could be caused by impaired maternal immune tolerance to a semi-allogenic conceptus (Hill, 1995a) . Many other factors involved in humoral and cellular immune responses may also in¯uence human reproductive failure. Traditionally, most of these have been studied from an immunological perspective; that is, they are identi®ed by immunological assays for antibodies and/ or antigens.
Although maternal and fetal immunology can be very dif®cult to investigate in humans, many mechanisms have been proposed to explain human reproductive failure (Table I ). The following review presents, the approximate developmental sequence, when immunological factors may in¯uence different stages of human pregnancy ( Figure 1 ).
Immunological factors from gamete development

HLA expression
The major histocompatibility complex (MHC), termed the human leukocyte antigens (HLA) in humans and MHC in other mammals, may in¯uence pregnancy from gamete development, embryo cleavage, blastocyst and trophoblast formation, implantation through fetal development and survival (Figure 1 ). Originally, HLA expression was evaluated using immunological assays for HLA antigens. More recently, molecular methods provide a clearer understanding of the involvement of HLA during pregnancy. For example, HLA expression on immature spermatozoa may function as signal molecules, or in¯uence gamete differentiation and maturation (Hutter and Dohr, 1998; Fernandez et al., 1999) . HLA expression also re¯ects increased embryo cleavage rates and is correlated with more successful implantation (Jurisicova et al., 1996) . HLA expression by blastocysts and trophoblasts (for review, see Le Bouteiller and Lenfant, 1996) , invading trophoblast (King et al., 1996b (King et al., , 2000a and maternal immune cells (King et al., 2000c) , may regulate maternal immune activity at the maternal-fetal interface, thereby in¯uencing implantation and subsequent fetal development. Studies in closely related human populations demonstrate that fetal development and survival may also be in¯uenced by parental or maternal/fetal sharing of particular HLA antigens (for reviews, see Ober and van Der Ven, 1997; Ober et al., 1998) . Thus, reproductive failure may result from aberrant expression of HLA antigens during any stage of pregnancy. A detailed discussion of the potential role of HLA expression in reproduction is described in Part II.
Antisperm antibodies
Antisperm antibodies (ASA) may also play an important role during pregnancy, but they predominantly in¯uence gamete development and fertilization (Figure 1 ). ASA can be produced by both sexes (Shulman, 1995) . Males can produce autoantibodies against their own spermatozoa and females can produce antibodies against a male's spermatozoa. It has been suggested that ASA may cause reproductive failure, since their presence in blood is associated with decreased fertility in both sexes (Mazumdar and Levine, 1998) . Although women generally possess higher ASA titres than men (Shulman, 1995) , ASA are found more frequently in men (Haas, 1996) . In males, ASA production arises from either systemic or local immune responses, and ASA are found in semen, seminal plasma, sera or bound to the outer sperm plasma membrane (Mazumdar and Levine, 1998) . In females, ASA are found in blood, ovarian follicular¯uid, vaginal or cervical secretions (Shulman, 1986a,b; Mazumdar and Levine, 1998) . ASA can be detected by many different methods. Unfortunately, neither superior antigens nor antibody detection Lenfant (1996) Ober et al. (1993) Hammer et al. (1997) assays exist (Cunningham et al., 1991; Helmerhorst et al., 1999 ; but see Mahmoud and Comhaire, 2000) and precise ASA prevalence estimations vary between assays due to differences in sample preparation, sensitivity, reliability, technical complexity and assay interpretation. In males, ASA may be produced before fertilization if the blood-testis barrier is breached and sperm antigens prompt an immune response. ASA production may result from damage, in¯ammation or mechanical obstruction of the genital tract (Alexander and Anderson, 1979; Mandelbaum et al., 1987) . Pathogens that cause sexually transmitted diseases may also cause ASA production, by attaching to spermatozoa and acting as foreign antigens. For example, ASA were found in 16.3% of serum and semen samples of 227 men (immunobead assay: positive titre >20% motile sperm binding) and antibodies to Chlamydia were found in 51.4% of ASA-positive men compared with 16.8% ASA-negative men (Witkin et al., 1995) . Liu et al. (1993) found that ASA-positive men had increased numbers of B cells and CD4:CD8 ratios, yet decreased numbers of CD4 and CD8 cells, when compared with ASA-negative men (n = 28). The authors suggested that ASA-positive men exhibited increased B cell functions and decreased T-cell functions. In females, ASA production in the genital tract may occur if spermatozoa are exposed to immune responses from mechanical or chemical disruption of the mucosal layer. ASA formation may also be induced from spermatozoa in the peritoneal cavity after transtubal passage (Mazumdar and Levine, 1998) or from in¯ammation after genital infection (Witkin and Toth, 1983; Cunningham et al., 1991) .
Although numerous studies have investigated the effects of ASA in both sexes, the precise mechanisms by which ASA affect fertility and reproduction remain questionable. In men, ASA may adversely affect sperm maturation, function or overall semen quality (Dimitrov et al., 1994) . ASA also interfere with sperm cervical mucus penetration (Menge and Beitner, 1989; Steen et al., 1994) . Reductions in sperm linearity, velocity and percentage motility have been detected in ASA-positive men (Upadhyaya et al., 1984; Mathur et al., 1986; Check et al., 1991; Eggert-Kruse et al., 1991) and partners of ASA-positive men attained fewer pregnancies than partners of ASA-negative men (Eggert-Kruse et al., 1991) . ASA may also interfere with sperm function by preventing the cholesterol loss from the sperm surface (capacitation) (Benoff et al., 1993) . ASA could cause female infertility at different stages of reproduction including postcoital sperm survival in the reproductive tract (Telang et al., 1978; Moghissi et al., 1980; Jager et al., 1981; Friberg, 1981; Menge et al., 1982; Mathur et al., 1984) . For example, Mathur et al. (1988a) studied ASA in sera, seminal¯uid and cervical mucus from 93 infertile and 40 fertile couples with double-¯uorochromasia cytotoxicity assays. In-vitro sperm survival and motility signi®cantly decreased when spermatozoa were incubated with male or female seminal plasma or cervical mucus with ASA. ASA may also interfere with fertilization by disrupting sperm±oocyte recognition and fusion (Fann and Lee, 1992) . Wolfe et al. (1995) suggested that particular classes of ASA may impair sperm± oocyte fusion. These researchers studied 29 couples, in which male partners' spermatozoa possessed >60% IgA or IgG ASA. Oocytes were fertilized by partner's spermatozoa with subzonal sperm insemination. Signi®cantly fewer fertilizations were achieved with IgG ASA-coated spermatozoa. Fertilization rates also decreased as the percentage of spermatozoa bound by IgG ASA increased. ASA may affect fertilization by blocking sperm binding to the zona pellucida (Tsuki et al., 1986; Zouari and De Almeida, 1993) or impairing sperm penetration of the oocyte (Bronson et al., 1981; Mahony and Alexander, 1991 ; but see Francavilla et al., 1991) .
ASA may also adversely affect early embryo cleavage. Naz (1992) suggested that speci®c sperm antigens provide a cleavage signal for oocyte division. In one couple undergoing IVF, isolated ASA were directed against a protein that inhibited embryo cleavage in a murine IVF model. Notably, normal embryonic cleavage occurred when the woman's oocytes were fertilized with donor spermatozoa. Recently, Tian et al. (1999) found signi®-cantly lower cleavage rates of IVF and embryo transfer in infertile women with ASA, compared with women without ASA (n = 150; P = 0.05).
Some research in the late 1980s found that ASA-negative women had higher rates of pregnancy than ASA-positive women (Haas et al., 1986; Witkin and David, 1988) and other studies found associations between ASA presence and reproductive failure (Yan, 1990; Zhang, 1990) . However, in these older studies serum samples were obtained only after pregnancy loss, suggesting that ASA may be a consequence, rather than a cause, of pregnancy loss (Simpson et al., 1996) . More recently, investigations have found no association between ASA and RSA ( Clarke and Baker, 1993; Simpson et al., 1996) . Indeed, Simpson et al. (1996) suggested that ASA do not play a major role in pregnancy loss in women not selected for infertility. Studies in women undergoing IVF suggest that ASA do not play a major role in reproductive outcome. For example, there was no signi®cant difference in IVF reproductive outcome between ASApositive and ASA-negative women (Janssen et al., 1992; Pagidas et al., 1994; Check et al., 1995; Nip et al., 1995) . There was also no signi®cant difference in IVF reproductive outcome for women with ASA-positive or ASA-negative male partners (Janssen et al., 1992; Rajah et al., 1993; Sukcharoen and Keith, 1995) . Thus, some studies argue for a role for ASA in reduced fecundity, fertilization and embryo cleavage.
Integrins
Integrins comprise a large family of transmembrane receptors, composed of non-covalently linked a and b subunits. These adhesion molecules are expressed by most cells, including cells involved in immune responses (Vinatier, 1995) . Integrins mediate cell-to-cell and cell-to-substratum interactions, which may be important during human fertilization, implantation and placental development (Figure 1 ). Integrins on human spermatozoa, such as membrane cofactor protein (MCP/CD46) (Anderson et al., 1993) , ®bronectin and vitronectin (Fusi et al., 1996a) , may facilitate sperm development and sperm±oocyte fusion. Speci®cally, the integrin receptor for ®bronectin (a 5 b 1 ), is up-regulated during capacitation and the integrin receptor for vitronectin (a v b 3 ) integrin is also up-regulated following the acrosome reaction (Fusi et al., 1996a) . Both ®bronectin and vitronectin are important extracellular matrix components required for sperm adhesion and penetration of oocytes (Fusi and Bronson, 1992; Fusi et al., 1996a,b) . Blocking antibodies to the a 5 b 1 and a v b 3 receptors inhibit attachment of human spermatozoa to zona-free hamster oocytes (Fusi et al., 1996b) . Other integrin subunits (a 3 , a 4 and a 6 ) have also been identi®ed in spermatozoa (Klentzeris et al., 1995) . Fertilin (PH 30), which contains a peptide sequence shared by many integrins (ARG-GLY-ASP), recognizes a murine oocyte integrin. Spermatozoa from mice lacking the b subunit of fertilin are unable to adhere to, or fuse with, oocytes (Cho et al., 1998) . Although the role of integrins during human sperm±oocyte binding remains controversial, human oocytes do express a unique repertoire of integrins including a 3 , a 6 , a v , b 1 , b 3 , b 4 and b 5 (Almeida et al., 1995; Campbell et al., 1995a) . Integrin expression on human embryos and trophoblasts has also been examined but their role in reproduction remains undetermined (for review, see Bowen and Hunt, 2000) .
Integrin expression is regulated spatially and temporally throughout the human menstrual cycle and during early pregnancy (Tabibzadeh, 1990; Lessey et al., 1992) . A remarkable similarity exists between integrin expression patterns in uterine epithelium in two species that experience invasive implantation, the human and baboon (Fazleabas et al., 1997; Lessey, 1998) . At least 10 integrin subunits are expressed by human uterine epithelium (for review, see Bowen and Hunt, 2000) and several heterodimers may be important during human implantation. For example, the a 9 b 1 integrin is strongly expressed on the uterine luminal epithelium throughout the human menstrual cycle, but it is only expressed on the glandular epithelium during the mid-to late-secretory phase (Lessey et al., 1996) . The a v b 3 integrin has also been implicated in human implantation (Lessey, 1998) as maximal a v b 3 expression in human uterine luminal epithelium coincides with progesterone rises during implantation. Unfortunately, few data are available on integrin expression by human trophoblast cells during implantation. However, cytotrophoblast cells alter their integrin pro®les during invasion of decidua (Bowen and Hunt, 2000) and the a 5 b 1 integrin may control the rate of blastocyst migration and decidual invasion (Damsky et al., 1992) . A lack of switching of integrin expression patterns may be associated with human reproductive failure since cytotrophoblast cells from human pre-eclamptic placentae do not switch adhesion molecule expression during migration in maternal tissue (Zhou et al., 1997) .
Integrins have also been associated with reproductive failure in infertile women and women with unexplained infertility. Lack of a 4 or b 3 integrin subunit expression has been associated with unexplained infertility in women (Lessey et al., 1995) . These subunits are speci®cally co-expressed in the glandular and luminal epithelium during maximal uterine receptivity and Lessey et al. (1992) reported that infertile women have delayed expression of the b 3 subunit of the a 5 b 3 integrin in luminal and glandular epithelium. Thus, disrupted integrin expression may be associated with decreased uterine receptivity (for review, see Bowen and Hunt, 2000) . Taken together, these studies demonstrate the need for further investigations to clarify the role of integrins during reproduction.
Leukaemia inhibitory factor
Leukaemia inhibitory factor (LIF) may regulate early interactions between the maternal reproductive system and the oocyte, embryo and blastocyst. Although LIF exhibits many functions in different tissues (Hilton and Gough, 1991 ; Hilton and Nicola, 1992) , it may be important during gamete development, embryonic and blastocyst development and implantation (Figure 1 ). LIF is a secreted glycoprotein and can be classi®ed with the gp130 cytokines, which share a signal transducing subunit (gp130) in their receptor-transducer mechanism (Sa Ânchez-Cuenca et al., 1999) . Signal transduction is achieved when LIF binds to the LIF receptor (LIF-R) and membrane-bound gp130 (Gearing et al., 1992) .
LIF may be important during oocyte development since ovarian granulosa-theca cells from pre-ovulatory follicles and stromal cells express LIF mRNA and protein (Arici et al., 1997) . Coskun et al. (1998) reported that the average LIF concentration is signi®cantly higher in pre-ovulatory follicles than immature follicles. LIF expression has also been detected in follicular¯uid, an important micro-environment for oocyte maturation, oocyte transport during ovulation, fertilization and early embryonic development (Senturk and Arici, 1998) . LIF follicular¯uid concentration increases during ovulation and is positively correlated with embryonic development (Arici et al., 1997) . However, Ozornek et al. (1999) reported that LIF follicular¯uid concentration was not associated with successful development of IVF embryos. Thus, the in¯uence of LIF in follicular¯uid upon embryonic development remains controversial.
The Fallopian tube also in¯uences oocyte transport, fertilization, embryonic stem cell proliferation and embryo transport. Thus, early embryo development may be regulated by Fallopian LIF expression (Senturk and Arici, 1998) , since LIF is both expressed and secreted by Fallopian epithelial cells in a highly constitutive pattern (Keltz et al., 1996) and human LIF improves the viability of ovine embryos and increases murine trophectoderm mass (Fry et al., 1992) . Importantly, oocytes express LIF-R, embryonic stem cells express LIF-R (Charnock-Jones et al., 1994), 3-cell embryos and morula express gp130 mRNA and most in-vitro human embryos express both LIF and LIF-R (Chen et al., 1999) . This suggests that there may be interactions between LIF and the embryo during development. However, one study reported that the expression of LIF, LIF-R and gp130 mRNA differs during in-vivo and in-vitro bovine oocyte maturation to early embryonic development, suggesting that LIF system mRNA expression patterns may be disrupted in in-vitro systems (Eckert and Niemann, 1998) .
Although the importance of LIF during gamete and early embryonic development remains controversial, LIF expression is critical for blastocyst development and implantation in humans. Speci®cally, LIF expression enhances human blastocyst formation and modulates in-vitro trophoblast differentiation (Dunglinson et al., 1996; Nachtigall et al., 1996) . LIF also drives the human trophoblast differentiation pathway towards the adhesive phenotype required for implantation: LIF inhibits metalloproteinase secretion, increases deposition of fetal ®bro-nectin into the extracellular matrix and inhibits cytotrophoblastic differentiation into syncytium (Bischof et al., 1995) .
Many studies have investigated LIF and LIF-R expression in the human endometrium and blastocyst during implantation. LIF expression is regulated in the endometrium throughout the menstrual cycle, with maximal expression occurring during days 19-25 of the implantation period (Arici et al., 1995) . Generally, LIF is secreted by endometrial epithelial and stromal cells and Part I: Immunological factors decidual cells (Kojima et al., 1994; Arici et al., 1995; Cullinan et al., 1996) . Strong LIF mRNA expression has also been detected in decidual leukocytes abundant at the implantation site . Moreover, strong LIF mRNA expression has been detected in CD45 + cells in the decidua, of which the majority are uterine NK cells (Bulmer et al., 1991) . However, there are con¯icting reports regarding trophoblast expression of LIF (Sawai et al., 1995; Nachtigall et al., 1996; Sharkey et al., 1999) . LIF-R is expressed by endometrial cells (Kojima et al., 1995; Cullinan et al., 1996) and by preimplantation blastocysts (Charnock-Jones et al., 1994; van Eijk et al., 1996) . In particular, LIF-R mRNA and protein have been detected in fetal villous and extravillous trophoblast and in endothelial cells of fetal villi . Thus, there may be a speci®c interaction between the implanting blastocyst and the endothelium and leukocytes of the maternal reproductive system. Sharkey et al. (1999) have proposed that LIF mediates interactions between maternal decidual leukocytes and trophoblast invading the decidua, since invading extravillous trophoblast expresses LIF-R as it moves past decidual leukocytes and endothelial cells expressing LIF mRNA.
Changes in LIF expression in the human endometrium have been associated with human reproductive failure during the implantation period. In-vitro endometrial explant cultures from fertile women secrete signi®cantly higher LIF concentrations during the secretory phase (implantation period) than the proliferative phase (n = 17; P < 0.05). In contrast, infertile women do not exhibit changes in LIF expression. Women who experienced multiple implantation failures during IVF demonstrated decreased LIF secretion during the secretory phase (n = 32). On the other hand, fertile women secreted 2.2-fold higher LIF concentrations than infertile women during the secretory phase (P < 0.05) (Hambartsoumian, 1998) . In-vivo studies of LIF concentrations, measured from the uterine¯ushings of fertile and infertile women and women with recurrent miscarriage, revealed decreased concentrations in women with unexplained infertility (Laird et al., 1997) . Thus, LIF plays an important role during human blastocyst development and implantation. However, further studies are required to clarify maternal-fetal LIF interactions during these early reproductive stages.
Cytokines in gamete development
Cytokines are small, secreted, membrane-bound proteins that act through cell-surface receptors and generally induce changes in gene expression within their target cells. Cytokines produce effects in local cells and work over a short period of time (Parham, 2000) . They also play critical roles in pathogen response and regulation of cellular growth and differentiation. In general, most research has focused upon cytokine involvement during gamete development, implantation and later stages of pregnancy ( Figure 1 ).
Cytokines act as growth and differentiation factors in regulating testicular and glandular functions and they have also been shown to in¯uence spermatogenesis (Hales et al., 1999) . Comprehensive reviews of this topic have been prepared recently (Hales et al., 1999; Hales, 2000) . Additionally, a signi®cant amount of research has been directed toward the study of cytokines and ovarian function (for review, see Best, 2000).
Immunological factors from blastocyst/trophoblast formation
Antiphospholipid antibodies
Antiphospholipid antibodies (APA) are acquired IgG, IgM and/or IgA immunoglobins or monoclonal antibodies directed against negatively charged phospholipids associated with a slow progressive thrombosis and infarction in the placenta (Kutteh, 1997) . APA may in¯uence pregnancy from the blastocyst/ trophoblast stage through parturition (Figure 1 ). The bestcharacterized APA associated with reproductive failure are lupus anticoagulant (LA) and anticardiolipin (aCL). However, APA to other phospholipid antigens include phosphatidylserine (PS), phosphatidylinositol (PI), phosphatidylglycerol (PG), phophatidylethanolamine (PE) and phosphatidic acid (PA) (Kwak et al., 1992; Bahar et al., 1993; Matzner et al., 1994; Ruiz et al., 1995) . APA are a group of heterogeneous antibodies with different speci®cities (Rote and Ng, 1995) , circulating in the peripheral blood and peritoneal¯uid (D' Hooghe and Hill, 1995) and bind phospholipids from platelet membrane and other serum factors, such as Factor III, prothrombin, Factors Xa and V and calcium (Thiagarajan et al., 1980; Lockwood et al., 1986; Cowchock et al., 1988; Reece et al., 1990) . APA antigens vary in distribution. For example, PE, PC and PS antigens are the principal components of plasma membranes. In contrast, CL has a restricted distribution in the inner mitochondrial membrane (Ioannou and Golding, 1979; Daum, 1985; Dale and Robinson, 1988) .
Originally, APA were believed to bind only their directed antigens. However, studies demonstrate that aCL are directed against the CL antigen complexed with a 50 kDa plasma protein co-factor, b 2 -glycoprotein I (b 2 -GPI) (Galli et al., 1990; McNeil et al., 1990) . Other APA bind plasma-bound proteins apart from their antigens (Roubey, 1994; Sugi and McIntyre, 1996) . APA binding to phospholipids may be dependent on proteins, such as prothrombin, Factor Xa, protein C or S (Bevers et al., 1991; Roubey, 1994) , suggesting that APA may be a mixture of antibodies against b 2 -GPI and phospholipid epitopes that have been stabilized by their interaction with other proteins. Notably, Stern et al. (1998 Stern et al. ( , 2000a reported that IgM antibodies to the co-factor b 2 -GPI were associated with RSA and IVF failure.
Various methods are utilized to detect APA, and APA-positive women are characterized by having two positive tests, while not pregnant, at least 6 weeks apart (Kutteh, 1997) . However, the only assay currently standardized is for aCL, which involves the direct binding of the antibody to the cardiolipin antigen in an enzymelinked immunosorbent assay (ELISA) (Loizou et al., 1985; Branch et al., 1986; Harris et al., 1987) or phospholipid-coated glass beads (Obringer et al., 1995) . In contrast, there is no generally accepted criterion for LA detection (Exner et al., 1991) although various screening tests are available (for review, see Christiansen, 1997) . Serum standards for other APA are not available (Hill, 1995a) , although lack of assay standardization, rather than methodology, can in¯uence assay interpretation (Coulam, 1999) .
High concentrations of LA and aCL have been associated with clinical features of venous or arterial thrombosis, recurrent fetal loss and thrombocytopoenia. However, the most common complication of APA is the disturbance of pregnancy ( Rote and Ng, 1995) . Pregnant women with high APA concentrations may have greater risks of intrauterine growth retardation, placental abruption, prematurity, and early and severe pregnancy-induced hypertension (Kochenour et al., 1987; Branch et al., 1989) . APA are also clinically associated with diseases such as antiphospholipid antibody syndrome (Branch, 1998) .
Many mechanisms have been proposed to explain how APA cause reproductive failure (for review, see Kutteh et al., 1999) . For example, APA may affect placental development or hormone secretion, as in-vitro APA binding to trophoblast cells inhibits cytotrophoblast differentiation into syncytiotrophoblast, trophoblastic invasion and trophoblast hormone production . These interactions could subsequently result in placental disruption and pregnancy wastage (Coulam, 1999) . It is important to note, however, that the numerous mechanisms attributed to APA probably re¯ect their ubiquitous nature (Sherer and Shoenfeld, 1999) .
Prospective studies have con®rmed an association of APA and early reproductive failure. In these studies, 16% (Pattison et al., 1993) and 38% (Lockwood et al., 1989) of LA-or aCL-positive women had signi®cantly higher rates of subsequent pregnancy loss compared with negative controls. Additionally, different classes of APA immunoglobulin may have differential effects upon reproductive outcome. Women with IgM aCL antibodies, or low concentrations of IgG aCL, have signi®cantly lower risks of reproductive failure than women with LA, or medium to high concentrations of IgG aCL antibodies . The quantitative concentrations of APA may also in¯uence subsequent reproductive failure. Lockshin et al. (1989) found that women with >40 units of IgG aCL had greater fetal losses than women with <40 units. The rate of fetal death also increased with increasing concentrations of IgG aCL antibodies. Moreover, a history of fetal death may have additive affects on IgG aCL concentrations and thus increase subsequent risks of fetal loss. It is important to note, however, that the presence of APA does not necessarily cause APA-associated autoimmune disease since women without a history of reproductive failure have APA concentrations of 2±4% (Harris and Spinnato, 1991 Although APA could affect reproductive failure during the ®rst, second or third trimester, there is little agreement regarding the most frequent period of reproductive failure. A number of investigators demonstrated that 2±16% of women with recurrent reproductive failure during the ®rst trimester were APA-positive (Petri et al., 1987; Barbui et al., 1988; Out et al., 1991; Parazzini et al., 1991; Parke et al., 1991; Rai et al., 1995) . In constrast, a few studies reported no associations between APA and ®rst trimester miscarriages (Simpson et al., 1997) . Studies in infertile women have generally found an increased prevalence of APA in infertile women compared with fertile controls (for review, see Coulam et al., 1999) . However, a recent controversy has arisen over the importance of APA and early reproductive failure in infertile women undergoing IVF and embryo transfer. Four studies suggested that the presence of elevated APA reduced IVF reproductive outcome (Birkenfeld et al., 1994; Geva et al., 1994; Sher et al., 1994; Dmowski et al., 1995 (El-Roeiy et al., 1987; Gleicher et al., 1994; Sher et al., 1994; Birdsall et al., 1994; Denis et al., 1997; Kowalik et al., 1997; Kutteh et al., 1997) and found no signi®cant association between antiphospholipid abnormalities and clinical pregnancy. IVF pregnancy may be unaffected by high APA prevalence if APA have no direct relationship with IVF outcome (Gleicher, 1997) . On the other hand, if the major APA effects on reproductive outcome involve preimplantation development, as suggested by mouse studies (Tartakovsky et al., 1996) , then gamete fertilization and early embryo development in the laboratory may avoid in-vivo APA effects . Other studies, focusing on late ®rst trimester, second or third trimester reproductive failure, have found that APA-positive women experienced previous fetal loss rates of 41% (Branch et al., 1992) and subsequent fetal loss rates of 80% (Oshiro et al., 1996) compared with APA-negative controls. Thus, the relative importance and the stage during which APA may in¯uence human reproductive outcome remains highly controversial.
Studies attempting to link APA other than LA and aCL to RM have been fraught with dif®culties. One study by Branch et al. (1997) is a notable exception. The authors studied both IgG and IgM antibodies for six phospholipids normalized against an aCL standard, in 147 women with RM, 43 women with APS and 104 fertile controls; 18% and 3.4% of women with RM and 9% and 3.8% of controls were positive for IgG and IgM APA other than aCL respectively. In contrast, APA binding occurred in >90% of women diagnosed with APS. Branch and co-workers concluded that women with RM were no more likely to have elevated APA concentrations than fertile women and that testing for APA, other than LA and aCL, was not clinically useful. Branch (1998) later stated that his data neither adequately supported nor refuted the possible roles of other APA in RM.
Discrepancies between studies associating APA and reproductive failure may be due to the very different aetiologies of reproductive failure classi®ed in study groups or the variability in de®ning positive APA titres (Branch, 1998) . Moreover, intraindividual APA serum concentrations vary during gestation, suggesting that the time period of APA assay may greatly in¯uence study results (Topping et al., 1999) . For example, transiently positive APA results were noted in fertile women and transiently negative APA results were detected in some women with clinically de®ned APS during mid and late pregnancy (Topping et al., 1999) .
Anti-trophoblast antibodies
Anti-trophoblast antibodies are thought to be maternal immunoglobulins directed against fetal trophoblast antigens and may in¯uence blastocyst/trophoblast formation. Although early studies reported maternal antibody response to trophoblast cells in normal pregnancy (Hulka et al., 1963; Burstein and Blumenthal, 1969; Nakakita, 1972) , antibody assays utilized may not have been reliable. IgG and IgM antibodies have been primarily detected with ELISA during normal gestation. Antibody concentrations appear to decrease during subsequent pregnancies Davies and Browne, 1985) . However, serum samples in these earlier studies were not puri®ed to eliminate other antibodies, such as APA, and neither the antibodies nor the antigens have been de®nitively characterised.
Part I: Immunological factors
Therefore, anti-trophoblast detection by ELISA remains controversial (Hole et al., 1987) . Trophoblast antibody speci®city in ELISA has also yet to be determined, since trophoblast samples contain many allotypic proteins and maternal immunity to these proteins cannot be excluded (Kajino et al., 1988) . Most importantly, there is little consensus regarding the subpopulation of trophoblast to be used as antigens. Alternatively, Jalali and colleagues have used acid elution, long NIH cross matching and sodium dodecyl sulphate±polyacrylamide gel electrophoresis, to isolate maternal IgG antibody bound to a polymorphic antigen (R80K) in human syncytiotrophoblast (Jalali et al., 1989 (Jalali et al., , 1995 . These authors found that human antibodies to R80K suppressed NK cytotoxicity. Although this suggests that successful pregnancy may require IgG binding to R80K, only term placentae have been studied and further research is required to determine the importance of R80K during early pregnancy and reproductive success.
Other studies have attempted to link the presence of antitrophoblast antibody activity to reproductive failure. For example, McCrae et al. (1993) compared serum from 27 women with aCL, and a history of fetal loss, with 29 normal pregnant women. Signi®cantly greater numbers of women with aCL had antitrophoblast antibodies compared with controls (P < 0.001). The importance of these results remains uncertain, since women with aCL had previously experienced different forms of reproductive failure. Anti-trophoblast activity was also attributed to speci®c F(ab')-mediated monomeric IgG interactions with trophoblast antigens, despite fewer than ®ve samples being used to characterize this activity and failure to eliminate cross-reactivity with HLA antibodies. Other studies with small sample sizes have also supported the in¯uence of anti-trophoblast antibodies upon reproductive failure (Grimmer et al., 1988; Hasegawa et al., 1990) . However, these groups did not screen women for other causal factors of reproductive failure. Although few large-scale prospective studies have been conducted, Tedesco et al. (1997) demonstrated preliminary evidence for the presence of antitrophoblast antibodies in one large study of women with clinically de®ned RSA. Serum from 73 women with RSA was compared with serum from 56 women of comparable age with one or more normal pregnancies, 12 nulliparous women and 16 men. All samples were screened to eliminate other causal agents of spontaneous abortion, such as structural, genetic, endocrinological abnormalities, infectious agents and APA. Puri®ed IgG antibodies were tested for anti-trophoblast activity against intact trophoblast cells by an immuno¯uorescence assay. More than 50% of women with RSA produced anti-trophoblast antibodies (predominantly IgG) compared with 25% of the controls. Antitrophoblast antibodies may induce trophoblast cytotoxic killing by early and late complementary regulatory proteins (C3 and TCC respectively), since the proportions of these proteins were reported to differ between women with RSA and controls. TCC activity was only observed in women with RSA and the C3 protein was detected in >50% and 5% of women with RSA and controls respectively. Thus, Tedesco's work suggests that antitrophoblast antibodies may affect reproductive failure, but further study is required for con®rmation of these ®ndings. Additionally, the involvement of other accessory molecules with antitrophoblast antibodies requires further investigation.
Anti-endometrial antibodies
Anti-endometrial antibodies may also affect reproductive outcome and can be detected by several techniques, including passive haemagglutination (Chihal et al., 1986) , indirect immuno¯uorescence (Wild et al., 1992; Fernandez-Shaw et al., 1993) , ELISA (Nakayama et al., 1987; Odukoya et al., 1995) and immunoblotting (Mathur et al., 1988b; Gorai et al., 1993) . While several studies have found signi®cant associations concerning anti-endometrial antibodies in women with endometriosis (Kennedy et al., 1990; Fernandez-Shaw et al., 1993) , others have found no signi®cant associations (Fernandez-Shaw et al., 1996) . Indeed, there are opposing views on the relationship between endometriosis and infertility. Women with mild forms of endometriosis may have lower conception rates. Yet severe forms of endometriosis may interfere with ovulation and impair fertility (Reiss, 1998) . Two studies have investigated the signi®cance of anti-endometrial antibodies in women experiencing other forms of reproductive failure (Palacio et al., 1997; Eblen et al., 2000) . Palacio et al. (1997) detected positive anti-endometrial antibody responses to two carcinoma lines from 77. 8 and 66 .7% of women with ovulatory dysfunction, 54.5 and 45.5% of women with tubal obstruction, and 40 and 60% of women with unexplained infertility. Fertile controls did not demonstrate a positive response. Eblen et al. (2000) reported that antibodies from women with RSA and from multiparous women recognized 65 and 80 kDa proteins on normal endometrium. Endometrial IgG antibodies from women with RSA also bound 21 and 28 kDa endometrial tumour antigens at signi®cantly greater concentrations (12/15 and 13/15 respectively) than antibodies from healthy, multiparous women (5/20 and 8/20 respectively). While this research suggests a tentative relationship between anti-endometrial antibodies and RSA, it is unknown how these antibodies affect reproductive failure (Hatayama et al., 1996) and the type of antigen these antibodies recognize is not clearly de®ned.
Endometrial adhesion factors
Adhesion molecules regulate interactions between cells and between cells and tissue matrices (Reiss, 1998) . Unfortunately, nomenclature for adhesion factors is very complex and encompasses a wide range of factors, with many different names (Parham, 2000) . Endometrial adhesion factors regulate interactions between trophoblast/blastocyst cells and the endometrium during implantation. To mediate implantation, adhesion factors may be inducted on the endometrial luminal epithelium surface and act as receptors to ligands on the outer trophectodermal surface of the blastocyst (Aplin, 1997) .
Study of endometrial adhesion factors requires con®rmation of the duration of endometrial receptivity. Markers to detect physiological signals in the luteal endometrium have been developed to determine the commencement, and duration, of endometrial receptivity, also known as the`implantation window'. LH peaks immediately preceding ovulation and endometrial receptivity lasts from approximately day 20 to day 24 of the menstrual cycle, or from day LH+7 to LH+11 (Bergh and Navot, 1992) . A more accurate determination of endometrial receptivity is marked by the formation of pinopodes, smooth apical membrane projections of the endometrial epithelial cells. In rats, pinopode expression strictly coincides with implantation (Martel S.Roy Choudhury and L.A.Knapp et al., 1991) . The human implantation window is short in duration and varies between different women. In humans, pinopode expression lasts <48 h in all menstrual cycles and is correlated with the initiation of human implantation following embryo transfer. Unfortunately, pinopode formation can vary by 4 days between women (from days 19 to 22). Generally, however, pinopode formation occurs on days 20 and 21 (for review, see Nikas, 1999) .
Potential endometrial adhesion factors identi®ed at the maternal-fetal interface during implantation includes integrins (see`Immunological factors from gamete development'), the trophinin-tastin complex, CD44 and cad-11 (for review, see Aplin, 1997) . Trophinin and tastin are detected in trophoblast and endometrial epithelial cells, forming a cell adhesion molecule complex, which may mediate initial blastocyst attachment to uterine epithelial cells during implantation (Suzuki et al., 1998) . Moreover, trophinin expression is restricted to human secretory phase tissue (Fukuda et al., 1995) . CD44 may also be an endometrial adhesion factor, since it is selectively expressed by human embryos and blastocysts (Campbell et al., 1995b) and recognizes the types of ligands expressed on endometrial epithelium (Aplin, 1997) . CD44 expressed on T cells also regulates T cell migration into extravascular sites of in¯ammation (Ariel et al., 2000) and mediates leukocyte binding to endothelial cells (Johnson et al., 2000) . Some members of the cadherin (cad) family mediate calcium-dependent intercellular adhesion and may also in¯uence implantation. For example, cad-11 is speci®cally expressed in differentiating human villous cytotrophoblast cells, endometrial epithelial cells and up-regulated in decidualizing stromal cells (MacCalman et al., 1996) . Another adhesion molecule CEACAM1/CD66a/C-CAM/BGP, belonging to the carcinoembryonic antigen family, is expressed on the endometrial surface and glandular epithelia. Although absent on decidual cells, CEACAM1 was detected on endometrial epithelium, small endometrial vessels, extravillous trophoblast at the implantation site, and on cultured invasive extravillous trophoblast cells. Bamberger et al. (2000) suggest that CEACAM1 may mediate trophoblast and endometrial interactions during the trophoblastic invasion of the endometrium. Still other factors, such as the blood group H type I, the Lewis y antigen, lectins and heparan sulphate may also demonstrate adhesive properties during human pregnancy (for review, see Aplin, 1997) . Taken together, a number of potential endometrial adhesion factors have been identi®ed during the implantation period. Unfortunately, few studies have investigated the in¯uence of these factors upon human reproductive outcome.
Mucins
Mucins are a group of large glycoproteins that form mucus in the respiratory, gastrointestinal and urogenital tracts (Gendler and Spicer, 1995) . Mucins serve as lubricants and protect the underlying epithelial cells . At least nine human epithelial mucin genes have been identi®ed (Gendler and Spicer, 1995) . The majority of mucin reproductive research has focused upon the human mucin 1 (MUC1) gene due to the predominant expression in the human endometrium (Gipson et al., 1997) . The MUC1 gene, known as Muc-1 gene in other species, is a hormonally regulated product of endometrial glandular and luminal epithelium and is expressed as both membrane-bound and secreted isoforms (Aplin et al., 1996) . MUC1/Muc-1 expression in uterine epithelium has been reported in humans and other mammals with species-speci®c expression patterns . MUC1 is also expressed on the surface of mitogenactivated T cells, suggesting that MUC1 serves an immunomodulatory function in normal immune regulation (Agrawal et al., 1998) . In addition, mucins may prevent maternal bacterial infection and enzymatic attack (Jentoft, 1990) . They may also affect sperm access to the oocyte in the maternal reproductive tract (Aplin et al., 1996) . Several studies indicate that mucins prevent embryo attachment to uterine epithelia Ligtenberg et al., 1992; Wesseling et al., 1995) , since high concentrations of MUC1 at the cell surface inhibited cell±cell and cell-matrix adhesion and enzymatic removal of mucins from uterine epithelia converted maternal cells from the non-receptive state to the implantation state (for review, see DeSouza et al., 1999) . Thus, MUC1 may act as an anti-adhesion molecule. MUC1 may also inhibit blastocyst interactions with maternal uterine epithelium during implantation (Aplin, 1994; Aplin et al., 1994) . Recent work in humans and other mammals suggests that embryos may signal uterine epithelium to reduce mucin expression, enabling implantation to occur. Several studies have examined MUC1 expression in women experiencing pregnancy loss. Serle et al. (1994) reported that women with RM have reduced MUC1 concentrations in uterine¯ushings during the implantation period, after day LH+7. Similarly, Hey et al. (1995) found that MUC1 concentrations were signi®cantly lower by day LH+10 in women with RSA compared with fertile controls. These human studies support the role of MUC1 in reproductive outcome. If MUC1 inhibits implantation, reduced concentrations in women with reproductive failure may allow the implantation of less viable embryos. However, in fertile women, higher MUC1 concentrations during implantation offer an opportunity for prenatal selection (Aplin et al., 1996) . Thus, a number of human studies demonstrate that MUC1 expression in the endometrium may have critical roles during implantation and aberrant, or lack of, mucin expression could contribute to reproductive failure.
T-cells
T lymphocytes account for 45% of the leukocytes in the proliferative endometrium. However, during the secretory phase the proportion of T lymphocytes gradually decreases and uterine NK cells become the predominant leukocyte population (Bulmer et al., 1988; King et al., 1989; Starkey et al., 1991) . Some argue that T-cells are unimportant during pregnancy due to their reduction in number during the late secretory period and ®rst trimester of pregnancy (Vassiliadou and Bulmer, 1996a) . Moreover, no signi®cant differences in T-cell subpopulations have been detected during the menstrual cycle, or in ®rst-term deciduas of healthy women (Vassiliadou and Bulmer, 1996a) . In contrast, other authors argue that T-cells are important during pregnancy since they represent 20% of the leukocytes in late secretory endometrium and 20±30% of the leukocytes in ®rst trimester deciduas (Mincheva-Nilsson et al., 1992; Morii et al., 1993; Mincheva-Nilsson et al., 1994) . Signi®cantly increased Tcell proportions were prospectively detected in the endometria of women with RM who subsequently miscarried, compared with fertile women and women with RM who had successful pregnancies (Lachapelle et al., 1996; Quenby et al., 1999).
Controversy also surrounds the importance of T-cell recognition and activation by the ab and gd T-cell receptor (TCR) at the maternal±fetal interface. Vassiliadou and Bulmer (1996a) report that the majority of human decidual T-cells express the ab TCR. However, ab TCR do not recognize, or react to, trophoblast cells in the mouse (Arck et al., 1999) . gd T-cell recognition is not MHC-restricted (Hayday, 1999) , enabling these cells to recognize a different spectrum of antigens. Binding to MHC antigens can actually inhibit gd T-cell cytotoxic killing of MHC expressing cells, while reduced MHC expression does not inhibit gd T-cell target killing (Mingari et al., 1995; Phillips et al., 1995) . The presence and proportion of gd T-cells in human endometrium and decidua remains extremely controversial (Dietl et al., 1990; Maruyama et al., 1992; Mincheva-Nilsson et al., 1992; Chernyshov et al., 1993; Ditzian-Kadanoff et al., 1993; Morii et al., 1993; Vassiliadou and Bulmer, 1996a; Vassiliadou and Bulmer, 1998) . Some groups detect no gd T-cells in human decidua (Dietl et al., 1990) and other groups report very small proportions (Vassiliadou and Bulmer 1996a) . Still other groups report large numbers of gd T-cells (Mincheva-Nilsson et al., 1992) . This may be a consequence of inappropriate monoclonal gd TCR antibodies (Vassiliadou and Bulmer, 1996a) . Alternatively, in-situ immunostaining may be problematic due to the sensitivity of the gd epitope to both ®xation and freezing (Mincheva-Nilsson et al., 1997).
Ditzian- Kadanoff et al. (1993) reported increases in the proportion of gd T-cells during early human pregnancy. However, Vassiliadou and Bulmer (1996a) showed that the number of gd T-cells is similar in all phases of the menstrual cycle. Thus, the exact role of gd T-cells in human pregnancy remains speculative . Although ab T-cells form 90% of the peripheral T-cell populations, gd T-cells can be the predominate T-cell population in epithelial tissues (Parham, 2000) , suggesting that they may have important roles in the maternal uterine epithelia during pregnancy. For example, human decidual gd T-cells in the epithelium may prevent embryonic or placental infection (Janeway et al., 1988; Mincheva-Nilsson et al., 1992) . Interestingly, gd T-cells are the ®rst T-cell population produced by human embryos (Parham, 2000) , suggesting that embryonic and maternal gd T-cells may both regulate early reproduction. Some authors argue that gd T-cells regulate trophoblastic proliferation and implantation (Athanassakis et al., 1987; Heyborne et al., 1992; Vassiliadou and Bulmer, 1996a) . The predominate human decidual gd T-cells express the Vd1+ TCR, which mediates non-MHC-restricted cytotoxicity (Christmas et al., 1993; Ferrarini et al., 1996; MinchevaNilsson et al., 1997) . The majority of human peripheral gd Tcells, however, express the Vg9/Vd2 TCR (Lanier et al., 1988; Groh et al., 1989; Parker et al., 1990) . Barakonyi et al. (1999) reported that the ratio of peripheral Vg9/Vd2 gd T-cells was eight times greater in women experiencing RM than healthy pregnant women. In addition, Polgar et al. (1999) reported that healthy pregnant women (n = 22) had signi®cantly higher percentages of peripheral gd T-cells than women experiencing recurrent abortion and non-pregnant individuals (P < 0.001, n = 25). The importance of these ®ndings remains unclear, since the functions of decidual and peripheral gd T-cells may be completely different (Perker et al., 1980; Lanier et al., 1988; Groh et al., 1989 ; MinchevaNilsson et al., 1997). Thus, gd T-cells may have limited importance in pregnancy since they represent a very small proportion of decidual T-cells (Vassiliadou and Bulmer 1996a) and despite the great effort in gd T-cell research, few data are available concerning the function of these cells in human reproduction.
Peripheral natural killer cells
Natural killer (NK) cells, found throughout the body's circulatory system, may also contribute to human reproduction during many stages of pregnancy (Figure 1 ). These cells can be detected immunohistologically, with¯uorescence-activated cell sorting bȳ ow cytometry, or morphologically under an electron microscope (King et al., 1998 (Amino et al., 1982; Amino and Miyai, 1983) .
Several studies have attempted to associate peripheral NK cell activity with reproductive failure, since some women with RSA manifest a marked increase in peripheral NK cells (CD56 + and CD56 + /CD16 + ) during pregnancy compared with controls (Kwak et al., 1995) . Aoki et al. (1995) reported that women with RM and high preconceptional NK cell activity experienced signi®cantly greater rates of subsequent miscarriage compared with women with normal preconceptional NK concentrations. Coulam et al. (1995) reported that peripheral CD56 + concentrations predicted 86% of the reproductive outcome in women with RSA. However, CD56 + concentrations demonstrated low predictability for reproductive outcome in infertile women. Importantly, evaluating peripheral NK numbers as prognostic of reproductive failure may be unreliable. Gilman-Sachs et al. (1999) reported that only measuring NK cytoxicity by¯ow cytometry was reproducible and precise. Moreover, there was a lack of correlation between peripheral NK cytotoxicity and NK cell percentages or absolute numbers. Thus, earlier studies evaluating peripheral NK activity in women with RSA only by NK enumeration, may not have accurately determined NK activity.
Uterine natural killer cells
Although human studies suggest that peripheral NK activity is associated with reproduction, a subpopulation of NK-like cells at the maternal-fetal interface may be more actively involved during reproduction than peripheral NK cells. These NK-like cells are found in the uterine mucosa and are characterized by their phyloxinophilic, eosinophilic cytoplasmic granules (Bulmer et al., 1987a; . These cells are distinguished from peripheral NK cells by their unusual antigenic phenotype, with greater proportions of CD56 bright , CD16 -and CD3 - (King et al., 1998) . Cells with a similar phenotype account for <1% of peripheral blood lymphocytes, implying that there may be selective recruitment and/or local inductive NK cell proliferation in the uterus . These cells have many different names, including uterine NK cells, large granular lymphocytes, endometrial granulocytes, K cells, endometrial granulated lymphocytes (eGL) and decidual granulated lymphocytes (dGL). However, the term`uterine NK cells' can describe similar NK cells from different species and includes both endometrial and decidual cells. Moreover, this term differentiates NK cells in the blood from those in the uterus and includes both granular and agranular NK forms (King, 2000) .
Uterine NK cell concentrations vary in the endometrium and decidua. Low numbers of NK cells are present during the proliferative stage of the menstrual cycle. Numbers increase during the late secretory phase. If pregnancy occurs, uterine NK cell numbers remain high during early gestation (Bulmer et al., 1991; Loke et al., 1999) . During the secretory phase and early pregnancy, uterine NK cells account for~70% of decidual leukocytes (Bulmer et al., 1991; Nishikawa et al., 1991) , although they become less conspicuous after 20 weeks of gestation and are absent in term decidua (King et al., 1998) .
Several observations suggest that uterine NK cells may have important roles in reproduction. NK cells are hormonally regulated and closely associated with endometrial stromal cells and encircle vessels and glands (King, 2000) . Their numbers increase during the secretory phase when implantation occurs (King et al., 1989) . They are present during early gestation when placental cells`tap' into the maternal arteries (Bulmer et al., 1987b) , they are abundant in the decidua around in®ltrating extravillous trophoblast cells (Loke and King, 1995) and are the predominant stromal leukocyte population in normal ®rst trimester deciduas (Vassiliadou and Bulmer, 1996b) . This temporal and spatial association between uterine NK cells and placental trophoblast suggests that uterine NK cells may be pivotal in determining reproductive outcome (King and Loke, 1991) . In particular, they may in¯uence the growth, differentiation, breakdown and regeneration of cycling uterine mucosa (Boismenu and Havran, 1994) , decidualization (King, 2000) or perhaps trophoblast implantation, placental growth and development ( Loke and King, 1995) .
Reproductive outcome may be in¯uenced by changes in uterine NK cell numbers, phenotype or function (King, 2000) . Although reproductive outcome could not be predicted by measuring uterine NK cells in 20 women experiencing habitual abortion and 15 fertile controls, reproductive failure was associated with decreased numbers of CD16 -CD56 bright cells and increased numbers of CD56 + CD16 + cells in secretory phase endometria and placental biopsy specimens (Lea et al., 1995; Lachapelle et al., 1996) . Uterine NK cells may both promote or inhibit conceptus growth. CD16 -CD56 bright uterine NK cells can secrete cytokines to promote placental growth and CD16 + cells may inhibit conceptus growth by triggering NK cell target killing. Therefore, reproductive failure may result from an alteration of cytokine secretion from CD16 + cells, or from an imbalance between CD16 -CD56 bright and CD16 + CD56 dim cells (Lachapelle et al., 1996) . Reproductive failure may also be caused by increased concentrations of uterine NK cells with CD57 + markers (Vassiliadou and Bulmer, 1996b) . Vassiliadou and Bulmer (1996b) described signi®cantly increased numbers of uterine CD57 + NK cells in deciduas from spontaneous miscarriages compared with deciduas from normal pregnancy found increased numbers in non-pregnant endometrium from women with recurrent miscarriage. Signi®cantly elevated concentrations of CD57 + cells were also found at the implantation site of the deciduas of women with RSA compared with controls (n = 71, P = 0.03) (Kwak et al., 1999) .
Unfortunately, there are complications when associating both peripheral and uterine NK cells with reproductive failure. Firstly, there are differing patterns and densities of NK receptors between peripheral and uterine NK populations in the same individual. Thus, prospective studies attempting to link reproductive outcome to a particular maternal peripheral NK cell repertoire may not be valid. Uterine NK cells assayed from women undergoing spontaneous miscarriage (Maruyama et al., 1992; Chao et al., 1995) may be uninformative, since uterine NK cells may undergo apoptosis when progesterone concentrations decrease, either premenstrually or during reproductive failure (King et al., 1989) , resulting in decreased NK cell numbers. Also, secondary changes of in¯ammation and necrosis occur in tissues from women experiencing spontaneous miscarriage, which complicates interpretation of NK cell analysis (King et al., 1998) . Taken together, numerous studies indicate that NK cells, especially uterine NK cells, have important effects upon reproductive failure in humans.
Immunological factors from implantation
Cytokines and Th1/Th2 balance As discussed previously, cytokines can in¯uence cellular growth and diffentiation by acting through cell-surface receptors, which alter target cell gene expression (Parham, 2000) . Many different cells secrete cytokines in response to infections, including infections at the maternal±fetal interface. Recent studies demonstrate that cytokines can in¯uence reproduction during early gamete development, implantation and fetal development and survival (Figure 1) . The earliest cytokine research focused on cytokine secretion by T-cells. CD4 + T-helper (Th) lymphocytes differentiate into two subsets with distinctive functions and patterns of cytokine release. Originally, these two exclusive sets, Th1 and Th2, were classi®ed in vitro by using bioassays and ELISA. Th1 cells secrete cytokines such as interleukin-2 (IL-2), tumour necrosis factor b (TNF-b) or lymphotoxin and interferon g (IFN-g), and Th2 cells secrete IL-4, IL-5 and IL-10. Both Th1 and Th2 cells may secrete IL-3, IL-6, IL-12, IL-13, TNF-a, GM-CSF, encephalin and chemokine cytokines. Generally, Th1 and Th2 cytokines induce different effects. Th1 cytokines produce cytotoxic and in¯ammatory reactions, delayed-type hypersensitivity (DTH) and tissue injury in infectious and autoimmune diseases. Th2 cytokines encourage antibody production, particularly IgE responses, and enhance eosinophil proliferation and function ( Mosmann and Sad, 1996) . Th1/Th2 cytokines are mutually inhibitory, Th2 responses down-regulate Th1 responses and vice versa. Thus, the relative frequencies of these antagonistic cytokine subsets determine whether an immune response is protective or pathological (Yamamura et al., 1991; Mustafa et al., 1993; Romagnani, 1994; Elson et al., 1995; Liblau et al., 1995; Mosmann and Sad, 1996) . The maintenance of pregnancy may depend upon whether immune responses are protective or pathological, suggesting that cytokines may in¯uence reproductive outcome. Cytokines may directly, or indirectly, interfere with reproductive events depending upon the type of cytokine secreted, the cytokine concentration and the differentiation stage of target tissues (Hill, 1995a) . Generally, cytokines are involved in implantation, trophoblast invasion, decidualization, placental development and pregnancy immunotolerance (Clark, 1999) .
In 1987, Hill and colleagues demonstrated the importance of cytokines in normal pregnancy, and several years later Wegmann et al. (1993) postulated that pregnancy was a balance between Th1 and Th2 cytokine activity and that fetal survival would be improved if Th1 responses were inhibited by Th2 cytokines. The corollary of this hypothesis is that the effects of Th1-type cytokines contribute toward fetal loss (Raghupathy, 1997) and a de®ciency of particular cytokines important for pregnancy may lead to reduced placental development, subnormal fetal growth or even fetal death (Clark and Chaouat, 1989) . Although cytokine concentrations during human pregnancy have been measured, their speci®c effects on pregnancy have been determined by studying other species. Notably, Raghupathy (1997) suggests that the primary function of Th2 cytokines may be the prevention of a maternal Th1 response against the conceptus.
Complex Th1/Th2 pro®les have been detected in humans and, generally, there is no consensus that a shift in Th1 to Th2 immunity occurs during human pregnancy. For example, Tranchot-Diallo et al. (1997) did not detect a`classic' Th2 pro®le in pregnant women. In contrast, Reinhard et al. (1998) detected an increase in Th2 cytokines (IL-4) and a decrease in Th1 cytokines (IFN-g and IL-2) during, and soon after, normal pregnancy. There is also little agreement regarding cytokine shifts in women with RSA. For example, Schust and Hill (1996) found no association between pregnancy outcome in women with RSA and Th1 and Th2 cytokines and Pal® et al. (1999) did not detect a Th1 (IFN-g) to Th2 (IL-4) shift during pregnancy in women with RSA. However, Reinhard et al. (1998) reported a shift towards Th1 immunity in women with RSA. Unfortunately, most studies utilized only one or two cytokines as markers for Th2 and Th2 subsets, thereby underestimating the complexity of the shifts. Further studies of cytokine shifts are required, particularly in placental tissues, to demonstrate whether Th1/Th2 shifts are important for human pregnancy.
Although cytokine shifts have not been studied extensively in reproductive tissues, cytokine concentrations have been examined in the endometrium/decidua of women. Lim et al. (1998) reported predominant Th2 expression (IL-4, IL-6) compared with Th1 (IL-2, IL-12, IFN-g) cytokines by reverse transcription-polymerase chain reaction in 10 samples of normal peri-implantation endometrium. In women suffering from RM, signi®cantly lower IL-4 concentrations were detected in decidua compared with IL-4 concentrations in decidua from voluntary abortions and endometrial samples (Piccinni and Romagnani, 1996) . Recently, Okada et al. (2000) demonstrated that IL-15 mRNA was signi®cantly upregulated during the proliferative phase compared with the secretory phase in human endometrial samples (P < 0.01). The authors also reported that IL-15 was up-regulated during progesterone-induced decidualization, suggesting that IL-15 may play a role during menstruation and pregnancy. Cytokine patterns have also been examined in chorionic villi, the extensions of the chorion comprising of the outer syncytiotrophoblast cell layer and the inner cytotrophoblast layer. For example, Bennett et al. (1999) studied cytokine expresion in a small sample of ®ve fetal tissues obtained from women during the 7th-9th weeks of gestation. Th1 cytokines (IFN-g and IL-2) were not detected although low to moderate concentrations of macrophage-associated cytokines (IL-1a, IL-1b and TNF-a) were reported, which may be critical for fetal survival. High concentrations of IFN-a and IFN-b mRNA were detected, which may protect the fetus from maternal rejection and viral transmission. Moderate to high concentrations of Th2 cytokines, IL-6 and IL-10 mRNA were also detected (Bennett et al., 1999) . Cytokines such as IL-6 may also affect reproductive outcome, since they are involved in the cytokine cascade during infection and may induce preterm labour (Dudley et al., 1993) . Th2 expression of IL-10 has also been detected in cloned choriocarcinoma cells and puri®ed term trophoblast (Cadet et al., 1995; Bennett et al., 1996) . Th1 cytokines, IFN-g and TNF-a inhibited in-vitro proliferation of human trophoblast cells (Berkowitz et al., 1988; Haimovici et al., 1991; Yui et al., 1994) .
Studies have also investigated the in¯uence of peripheral blood mononuclear cells (PBMC) cytokine secretion on human reproductive outcome. During pregnancy, PBMC enhance progesterone production by the corpus luteum, facilitating and maintaining embryo implantation. Hashii et al. (1998) reported that PBMC co-cultured with corpus luteum cells secreted Th2 IL-4 and IL-10 cytokines and stimulated further progesterone production. Generally, in-vitro human trophoblast antigens activated the PBMC of RSA-susceptible women to produce soluble factors and Th1 cytokines toxic to mouse embryos and human trophoblast cell lines (Yamada et al., 1994; Hill, 1995b; Hill et al., 1987 Hill et al., , 1995 . For example, 66% of 244 women with RSA had PBMC which produced high concentrations of IFN-g and TNF-b (Th1) but low concentrations of IL-4 and IL-10 (Th2) to in-vitro trophoblast antigens. When exposed to placental cells and trophoblastic cell lines, PBMC of women with a history of successful pregnancy secreted signi®cantly higher concentrations of IL-6 and IL-10 (Th2) and lower concentrations of IFN-g compared with PBMC of women with RSA Ragupathy et al., 1999) . Similarly, Raghupathy et al. (2000) prospectively analysed PBMC cytokine secretion in women during the ®rst trimester of pregnancy. Women with a history of successful pregnancy (n = 24) secreted signi®cantly higher concentrations of Th2 cytokines and lower concentrations of Th1 cytokines compared with women with RSA (n = 23), who experienced an abortion. Szereday et al. (1997) reported signi®cantly increased IL-12 (Th1) concentrations and lower IL-S.Roy Choudhury and L.A.Knapp 10 (Th2) concentrations in women with RM or symptoms of premature reproductive failure (n = 120) compared with controls (n = 111). Moreover, women with successful pregnancies had signi®cantly higher IL-10 concentrations than women who experienced miscarriages. These studies suggest that cytokines may be important during many stages of pregnancy. Women who produce high Th1 cytokine concentrations may be unable to mount an appropriate Th2 response to fetal antigens, a reaction that would normally down-regulate Th1 responses and prevent pregnancy loss. However, a direct causal relationship between human cytokine production and human pregnancy loss has not been demonstrated.
Although human studies have demonstrated that cytokines have unique and important effects on pregnancy, the paradigm of two exclusive T helper cell subsets has been challenged. Many T-cell clones do not ®t the Th1/Th2 classi®cation (Maggi et al., 1988; Paliard et al., 1988) and cytokine subsets may exhibit more continuous distributions (Kelso, 1995) . Th1 and Th2 cells may secrete different cytokine subsets during development, possibly mediating alternate effects during gestation (Raghupathy, 1997) . Individual cytokines can also be regulated separately from their cytokine subsets. Research by Whiteside (1994) suggests that cytokines are multifunctional and pleiotropic and that cytokine activity is rarely exclusively in vivo. Haynes and Smith (1997) suggested that cytokines are in¯uenced by their concentration compared with other cytokines, regulatory molecules and coreceptors. Finally, classifying cytokine responses with Th1 and Th2 cells may be misleading (Kelso, 1995) since many other cells produce cytokines, including gd T-cells, CD8 + cells, NK cells, mast cells, B cells, basophils, macrophages and keratinocytes ( Mossman and Sad, 1996) . However, the identi®cation of cytokine-secreting cells important during human pregnancy requires further study.
Immunological factors affecting fetal development and survival
Anti-paternal (anti-HLA) antibodies Stimulated maternal B cells can produce antibodies directed against fetal HLA proteins, if intact fetal or trophoblast cells enter the maternal circulation. Mixed lymphocyte reactions (MLR), microlymphocytoxic and¯ow cytometric cross-matching tests have been used for anti-HLA antibody detection (for review, see Lubinski et al., 1993) . In the 1970s, studies reported anti-HLA antibodies in only 25% of primigravidae. Although antibody occurrence increased in multiparous women, only 43±63% of women with four or more pregnancies possessed these antibodies (Terasaki et al., 1970; Tongio et al., 1972) . Since anti-HLA antibodies were rarely found in women with RM, some research groups in the 1980s suggested that anti-HLA antibodies were necessary for normal pregnancy and that their absence could be a marker of inappropriate maternal immune response to the fetus (Taylor and Faulk, 1981; McIntyre et al., 1984; Mowbray et al., 1985) . Thus, anti-HLA antibodies were claimed to improve fetal survival in women with RM who possessed lower proportions of these antibodies compared with fertile women (Mowbray et al., 1985; Recurrent Miscarriage Immunotherapy Trialist Group, 1994) . In the 1990s, this notion was challenged. One prospective study detected anti-HLA antibodies in only 5% of women with successful pregnancies during the ®rst trimester, compared with an antibody prevalence of 10% in women who miscarried (Regan et al., 1991) . In a prospective immunization study, Christiansen et al. (1994) found higher frequencies of anti-HLA antibodies in women with RM who miscarried (29%) compared with 18% of women who successfully delivered. Currently, anti-HLA antibodies are not considered signi®cant factors associated with pregnancy maintenance, since these antibodies may be a normal consequence of later stages of pregnancy. This is supported by a prospective study of 226 normal pregnant women in which 62% of women with live births did not develop anti-HLA antibodies and most women who developed antibodies did so after 28 weeks of gestation (Regan and Braude, 1987) . Lower anti-HLA antibody concentrations in some women with RM may be due to pregnancy loss occurring before maternal antibodies are produced.
Blocking antibodies
Several studies have attempted to associate blocking antibody de®ciency and reproductive failure. It is assumed that an antifetal, maternal immune response is inhibited during pregnancy by the development of blocking antibodies. The absence of these blocking antibodies is assumed to result in reproductive failure (Hill, 1995a) . Blocking antibodies can be detected by positive inhibiting blocking effects of maternal sera in cellular in-vitro assays (Christiansen, 1997) , including one-way maternal-paternal MLR (Unander et al., 1985; Takakuwa et al., 1986) , the rosette inhibition test (Power et al., 1983) and tests for blocking production of migration inhibitory factor (Rocklin et al., 1976; Stimson et al., 1979) . Older studies reported that women with RSA lacked these blocking factors (Rocklin et al., 1976; Stimson et al., 1979; Takeuchi, 1980; Unander and Olding, 1983 ) and post-immunization MLR antibodies developed during early pregnancy were associated with reproductive success (Takakuwa et al., 1986; Unander and Lindholm, 1986; Beer, 1988) . Despite one recent study con®rming these ®ndings (Tamura et al., 1998) , few substantial data support blocking antibodies as predictors of successful reproductive outcome (Sargent et al., 1988; Coulam, 1992; Cowchock and Smith, 1992; Gleicher, 1994) . In fact, none of the presumptions of blocking antibody de®ciency have been validated and normal pregnancies are maintained without these antibodies (Sargent et al., 1988) . Furthermore, features of the immunological activity of blocking antibodies have been suggested ( McIntyre and Faulk, 1982; Power et al., 1983; Catto et al., 1986; Unander 1997 ), but not de®nitively characterized. Moreover, a speci®c, standardized and veri®able assay has not been de®ned (Hill, 1995a) . Finally, Neppert et al. (1989) demonstrated that antibody detection was poorly reproducible between laboratories. Thus, there are few recent data supporting the roles of these blocking antibodies during pregnancy.
Suppressor cells
The existence, and role, of suppressor cells during pregnancy is also controversial (Adorini et al., 1993) . It has been argued that suppressor cells suppress the maternal immune system and that a de®ciency of these factors results in fetal loss. Unfortunately, there is little consensus regarding the source and nature of suppressor cells, although they may include T-cells speci®c for Part I: Immunological factors trophoblast cells, endometrial/decidual factors, steroid hormones or unspeci®ed proteins and glycoproteins (Saji, 1993) . Suppressor cells have been identi®ed by their secretory products, such as IL-2 blocking factors, prostaglandin E 2 or TGF-b2 (Clark et al., 1986; Taw®k et al., 1986; Lala et al., 1987; Lea et al., 1995) . Human suppressor activity has been evaluated by using crude placental extracts, cultured supernatants from placental extracts, cultured supernatants from choriocarcinomas and teratocarcinoma lines (for review, see Markert and Chaouat, 1997) . Few studies have detected suppressor cells in humans, although Nobel (1984) found de®ciencies of decidual suppressor cells in endometrial biopsies from women following IVF. Lea et al. (1995) reported that 50% of women with RSA (n = 14) were de®cient in TGF-b2-producing suppressor cells in decidua. Since suppressor cells have been detected in only a few human studies, the characterization or speci®city of these cells has not been determined and there are no standardized or veri®able protocols.
Summary and conclusion
Numerous immunological factors could contribute to human reproductive failure; yet the relative importance of each factor remains controversial. Recent research suggests that HLA expression, ASA, integrins, LIF, cytokines, APA, endometrial adhesion factors, MUC1 and uterine natural killer cells are all involved in reproduction (Figure 1) . In contrast, few data support the roles of anti-trophoblast antibodies, anti-endometrial antibodies, T-cells, peripheral natural killer cells, anti-HLA antibodies and de®ciencies of blocking antibodies and suppressor cells in reproductive outcome.
Aberrant human leukocyte antigen (HLA) expression could adversely in¯uence gamete development, embryo cleavage rates, blastocyst and trophoblast formation, implantation, fetal development and survival. A comprehensive discussion of HLA expression and function is given in Part II.
Antisperm antibodies predominantly in¯uence gamete development, fertilization and possibly embryo cleavage. Generally, ASA in men adversely affect sperm maturation, function or overall semen quality (Dimitrov et al., 1994) . In women, ASA affect postcoital sperm survival in the reproductive tract (Mathur et al., 1984) , sperm±oocyte recognition and fusion (Fann and Lee, 1992) and early embryo cleavage (Naz, 1992) . Generally, studies demonstrate that ASA do not in¯uence reproductive outcome in couples undergoing IVF. The majority of ASA research has focused on how ASA affect male fertility and further studies are required to clarify ASA and female reproduction. Additionally, there remains a critical need to standardize testing procedures, antibody titres and assay interpretation for ASA.
Integrins may in¯uence early stages of reproduction such as fertilization, implantation and development (Figure 1 ). Speci®c integrin pro®les have been detected in spermatozoa (Klentzeris et al., 1995) and oocytes (Almeida et al., 1995; Campbell et al., 1995a) , which may facilitate sperm development and sperm± oocyte fusion (Fusi and Bronson, 1992; Fusi et al., 1996a,b) . Integrins may be important during implantation, since human uterine epithelium expresses at least 10 integrin subunits during this period (for review, see Bowen and Hunt, 2000) . Additionally, speci®c integrins and/or altered integrin expression may control the rate of blastocyst migration and decidual invasion (Damsky et al., 1992; Bowen and Hunt, 2000) . Notably, human reproductive failure has been associated with a lack of trophoblast integrin pro®le switching and with delayed integrin expression (Lessey et al., 1992 (Lessey et al., , 1995 Zhou et al., 1997) .
Although the importance of LIF during gamete and early embryonic development remains controversial, LIF regulation of blastocyst/trophoblast formation and differentiation is wellsupported by human studies. In particular, LIF drives the human trophoblast differentiation pathway towards the adhesive phenotype required for implantation (Bischof et al., 1995; Dunglinson et al., 1996; Nachtigall et al., 1996) . LIF may regulate interactions between maternal decidual leukocytes and the blastocyst during implantation . Studies also demonstrate that fertile women secrete higher concentrations of LIF than women with reproductive failure during the implantation period (Arici et al., 1995; Hambartsoumian, 1998) ; however, further research is required.
Cytokines also have many effects upon reproduction and are involved in gamete development (Norman and Bra Ènnstrom, 1996; Hales, 2000) implantation, trophoblast invasion, decidualization, placental development and pregnancy immunotolerance (Clark, 1999) . Generally, Th1 cytokines can damage placental trophoblast or have adverse effects on the conceptus, by direct embryotoxic activity (Hill, 1991) . Th2 cytokines may prevent a maternal Th1 response against the conceptus (Raghupathy, 1997a) . In addition, complex cytokine patterns have been detected in humans and these shifts are not unanimously associated with human reproductive outcome. Although a direct causal relationship between human cytokine production and pregnancy loss has not been determined, differences in cytokine activity have been reported for fertile women and those experiencing reproductive failure.
Antiphospholipid antibodies affect placental development, hormone secretion, endothelial and trophoblast development (for review, see Kutteh et al., 1999) . Yet their numerous roles may re¯ect their ubiquitous nature (Sherer and Shonefeld, 1999) . Quantitative APA concentrations and different classes of APA may in¯uence reproductive outcome, although the importance of APA other than aCL and LA remains controversial. Despite the large amount of APA data available, inconsistencies in study population selection, use of different assays and disparate interpretation of data produce large discrepancies between studies (Branch, 1998; Coulam, 1999) . Moreover, the relative importance and the stage during which APA may in¯uence human reproductive outcome remains hightly controversial.
Recently, numerous endometrial adhesion factors which could regulate interactions between trophoblast/blastocyst cells and the endometrium during implantation have been identi®ed. Some factors, such as trophinin and tastin, form a cell adhesion complex that regulates implantation (Suzuki et al., 1998) . Further studies are required to determine the in¯uence of these factors upon human reproductive outcome. Endometrial receptivity may also be greatly in¯uenced by the expression of anti-adhesion molecules, such as MUC1, in the endometrium or decidua. Although high MUC1 expression prevents primate blastocyst implantation, the blastocyst may signal MUC1 reduction during implantation, suggesting that MUC1 expression may act as a selective maternal mechanism for viable embryos . Women with histories of reproductive failure also demonstrate lower concentrations of MUC1 during the implantation period compared with fertile women (Serle et al., 1994; Hey et al., 1995) .
Uterine natural killer cells are a major ®eld of study in reproductive immunology, due to their large receptor diversity and their predominant presence at the maternal-fetal interface (King et al., 1998) from blastocyst/trophoblast development onwards. NK cells may have direct interactions with trophoblast cells (King et al., 1996b) or with the decidua and/or maternal vasculature (Croy et al., 1997) . The recognition of trophoblast cells by uterine NK cells may be important in inhibiting NK target killing, blastocyst implantation, placental growth and development ( Loke and King, 1995) .
Taken together, immunological factors play important roles during many stages of reproduction. Numerous studies suggest that aberrant, or lack of, expression of these factors may result in reproductive failure. Assays for these immunological factors are in¯uenced by both typing reagent quality and cell isolation techniques. Unfortunately, assay results can be unreliable and poorly reproducible between laboratories. For this reason, much controversy surrounds the relative importance of many immunological factors. In contrast, molecular assays have greater reproducibility, reliability and accuracy, and they may be used to standardize immunological assays.
Human reproduction may also be in¯uenced by genes encoding immunological factors, or regulatory mechanisms controlling their expression. Thus, it is increasingly important to study human reproduction from an immunogenetic perspective by using molecular methods. Extensive data on immunological factors involved in reproductive failure from humans have been summarized in Part I of this review. In Part II, immunogenetic and interacting factors involved in human reproductive failure will be presented.
